Literature DB >> 15364937

Catalytic domain crystal structure of protein kinase C-theta (PKCtheta).

Zhang-Bao Xu1, Divya Chaudhary, Stephane Olland, Scott Wolfrom, Robert Czerwinski, Karl Malakian, Laura Lin, Mark L Stahl, Diane Joseph-McCarthy, Christina Benander, Lori Fitz, Rita Greco, William S Somers, Lidia Mosyak.   

Abstract

A member of the novel protein kinase C (PKC) subfamily, PKC, is an essential component of the T cell synapse and is required for optimal T cell activation and interleukin-2 production. Selective involvement of PKC in TCR signaling makes this enzyme an attractive therapeutic target in T cell-mediated disease processes. In this report we describe the crystal structure of the catalytic domain of PKC at 2.0-A resolution. Human recombinant PKC kinase domain was expressed in bacteria as catalytically active phosphorylated enzyme and co-crystallized with its subnanomolar, ATP site inhibitor staurosporine. The structure follows the classic bilobal kinase fold and shows the enzyme in its active conformation and phosphorylated state. Inhibitory interactions between conserved features of staurosporine and the ATP-binding cleft are accompanied by closing of the glycine-rich loop, which also maintains an inhibitory arrangement by blocking the phosphate recognition subsite. The two major phosphorylation sites, Thr-538 in the activation loop and Ser-695 in the hydrophobic motif, are both occupied in the structure, playing key roles in stabilizing active conformation of the enzyme and indicative of PKC autocatalytic phosphorylation and activation during bacterial expression. The PKC-staurosporine complex represents the first kinase domain crystal structure of any PKC isotypes to be determined and as such should provide valuable insight into PKC specificity and into rational drug design strategies for PKC selective leads.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364937     DOI: 10.1074/jbc.M409216200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.

Authors:  Matthias Engel; Valerie Hindie; Laura A Lopez-Garcia; Adriana Stroba; Francis Schaeffer; Iris Adrian; Jochen Imig; Leila Idrissova; Wolfgang Nastainczyk; Stefan Zeuzem; Pedro M Alzari; Rolf W Hartmann; Albrecht Piiper; Ricardo M Biondi
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

2.  Conformational transitions of adenylate kinase: switching by cracking.

Authors:  Paul C Whitford; Osamu Miyashita; Yaakov Levy; José N Onuchic
Journal:  J Mol Biol       Date:  2006-12-05       Impact factor: 5.469

3.  Analysis on sliding helices and strands in protein structural comparisons: a case study with protein kinases.

Authors:  V S Gowri; K Anamika; S Gore; N Srinivasan
Journal:  J Biosci       Date:  2007-08       Impact factor: 1.826

4.  Reconstitution of modular PDK1 functions on trans-splicing of the regulatory PH and catalytic kinase domains.

Authors:  Hassan Al-Ali; Timothy J Ragan; Xinxin Gao; Thomas K Harris
Journal:  Bioconjug Chem       Date:  2007-05-15       Impact factor: 4.774

Review 5.  The life and death of protein kinase C.

Authors:  Christine M Gould; Alexandra C Newton
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

6.  A fitness-based interferential genetics approach using hypertoxic/inactive gene alleles as references.

Authors:  Jacques H Daniel
Journal:  Mol Genet Genomics       Date:  2009-01-17       Impact factor: 3.291

Review 7.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

8.  Staurosporine-derived inhibitors broaden the scope of analog-sensitive kinase technology.

Authors:  Michael S Lopez; Jonathan W Choy; Ulf Peters; Martin L Sos; David O Morgan; Kevan M Shokat
Journal:  J Am Chem Soc       Date:  2013-11-20       Impact factor: 15.419

Review 9.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

10.  Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.

Authors:  Caitlin E Cassidy; William N Setzer
Journal:  J Mol Model       Date:  2009-07-15       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.